LivaNova R&D Spending Growth & History (LIVN)
LivaNova's r&d spending was $185.8M for fiscal 2025.
View full LivaNova company overviewLivaNova annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $185.8M | $3.3M | +1.78% |
| 2024 | 2024-12-31 | $182.5M | −$11.3M | −5.83% |
| 2023 | 2023-12-31 | $193.8M | $38.0M | +24.40% |
| 2022 | 2022-12-31 | $155.8M | −$27.6M | −15.05% |
| 2021 | 2021-12-31 | $183.4M | $30.5M | +19.96% |
| 2020 | 2020-12-31 | $152.9M | $6.1M | +4.12% |
| 2019 | 2019-12-31 | $146.8M | $901,000 | +0.62% |
| 2018 | 2018-12-31 | $145.9M | $36.4M | +33.27% |
| 2017 | 2017-12-31 | $109.5M | $27.4M | +33.43% |
| 2016 | 2016-12-31 | $82.1M | $30.1M | +58.05% |
| 2015 · Dec 31 | 2015-12-31 | $51.9M | — | — |
| 2015 · Apr 24 | 2015-04-24 | $42.2M | −$3.0M | −6.58% |
| 2014 | 2014-04-25 | $45.2M | $3.7M | +8.83% |
| 2013 | 2013-04-26 | $41.6M | — | — |
LivaNova quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $53.7M | $6.5M | +13.73% |
| Q1 2026 | 2026-03-31 | $58.7M | $20.8M | +54.95% |
| Q4 2025 | 2025-12-31 | $52.1M | $8.8M | +20.35% |
| Q3 2025 | 2025-09-30 | $48.6M | −$228,000 | −0.47% |
| Q2 2025 | 2025-06-30 | $47.2M | $2.4M | +5.47% |
| Q1 2025 | 2025-03-31 | $37.9M | −$7.8M | −17.05% |
| Q4 2024 | 2024-12-31 | $43.3M | −$2.9M | −6.19% |
| Q3 2024 | 2024-09-30 | $48.8M | $2.3M | +4.86% |
| Q2 2024 | 2024-06-30 | $44.7M | −$6.4M | −12.49% |
| Q1 2024 | 2024-03-31 | $45.7M | −$4.3M | −8.65% |
| Q4 2023 | 2023-12-31 | $46.2M | $1.2M | +2.74% |
| Q3 2023 | 2023-09-30 | $46.5M | $10.8M | +30.28% |
| Q2 2023 | 2023-06-30 | $51.1M | $16.9M | +49.36% |
| Q1 2023 | 2023-03-31 | $50.0M | $9.1M | +22.16% |
| Q4 2022 | 2022-12-31 | $44.9M | $834,000 | +1.89% |
| Q3 2022 | 2022-09-30 | $35.7M | −$6.4M | −15.21% |
| Q2 2022 | 2022-06-30 | $34.2M | −$18.3M | −34.87% |
| Q1 2022 | 2022-03-31 | $40.9M | −$3.7M | −8.31% |
| Q4 2021 | 2021-12-31 | $44.1M | −$381,000 | −0.86% |
| Q3 2021 | 2021-09-30 | $42.1M | −$5.2M | −11.05% |
| Q2 2021 | 2021-06-30 | $52.6M | $27.4M | +108.96% |
| Q1 2021 | 2021-03-31 | $44.6M | $8.7M | +24.30% |
| Q4 2020 | 2020-12-31 | $44.5M | $21.7M | +94.87% |
| Q3 2020 | 2020-09-30 | $47.4M | $1.5M | +3.19% |
| Q2 2020 | 2020-06-30 | $25.2M | −$9.4M | −27.19% |
| Q1 2020 | 2020-03-31 | $35.9M | −$7.7M | −17.61% |
| Q4 2019 | 2019-12-31 | $22.8M | −$14.7M | −39.23% |
| Q3 2019 | 2019-09-30 | $45.9M | $3.5M | +8.22% |
| Q2 2019 | 2019-06-30 | $34.5M | $329,000 | +0.96% |
| Q1 2019 | 2019-03-31 | $43.6M | $11.8M | +37.24% |
| Q4 2018 | 2018-12-31 | $37.6M | $5.2M | +15.96% |
| Q3 2018 | 2018-09-30 | $42.4M | $19.5M | +85.20% |
| Q2 2018 | 2018-06-30 | $34.2M | $382,000 | +1.13% |
| Q1 2018 | 2018-03-31 | $31.8M | $11.4M | +55.75% |
| Q4 2017 | 2017-12-31 | $32.4M | — | — |
| Q3 2017 | 2017-09-30 | $22.9M | −$9.3M | −28.82% |
| Q2 2017 | 2017-06-30 | $33.8M | $3.6M | +11.99% |
| Q1 2017 | 2017-03-31 | $20.4M | −$11.3M | −35.67% |
| Q3 2016 | 2016-09-30 | $32.2M | — | — |
| Q2 2016 · Jun 30 | 2016-06-30 | $30.2M | — | — |
| Q1 2016 · Mar 31 | 2016-03-31 | $31.7M | — | — |
| Q2 2016 · Oct 18 | 2015-10-18 | $14.7M | $3.9M | +36.26% |
| Q2 2016 · Sep 30 | 2015-09-30 | $0 | — | — |
| Q1 2016 · Jul 24 | 2015-07-24 | $9.8M | — | — |
| Q4 2015 · Apr 24 | 2015-04-24 | $10.7M | — | — |
| Q2 2015 | 2014-10-24 | $10.8M | — | — |
LivaNova r&d spending trends
Over the last five fiscal years, LivaNova's r&d spending increased from $152.9M to $185.8M, a change of $32.9M. The latest reported quarter, Q2 2026, shows $53.7M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LivaNova source filings ↗